Alliance aims to help health workers in poor countries challenge corruption, excessive pricing, and waste of drugsBMJ 2008; 336 doi: https://doi.org/10.1136/bmj.a124 (Published 22 May 2008) Cite this as: BMJ 2008;336:1155
- Peter Moszynski
A new initiative to help increase access to essential drugs in developing countries was launched last week by development secretary Douglas Alexander.
The Medicines Transparency Alliance (MeTA) brings together various international institutions—including the World Health Organization and World Bank—governments, civil society, and business to tackle problems with drug supplies, quality, and affordability and thus “improve the health of some of the world’s most disadvantaged people.”
The Department for International Development (DfID) stated: “One in three people around the world still don’t have access to the basic medicines they need to fight illness and ten …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial